Pressure Bio, Digilab Join in Co-marketing, R&D Effort | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences and Digilab have struck an agreement to co-market and sell their product lines together worldwide and to pursue joint research and development projects, Digilab said today.

The companies plan to co-market their respective technologies through industry publications, at scientific meetings, through their websites, at trade shows, and through common collaborator studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.